Key result
Therapeutic alliance-based interventions improve medication adherence in Black patients with diabetes and hypertension.
Why the study?
Systematic evidence of successful interventions to improve medication adherence in Black patients with diabetes, hypertension, and kidney disease is lacking, and the impact of therapeutic alliance remains unclear.
Do interventions incorporating therapeutic alliance improve medication adherence in Black patients with diabetes, hypertension, and kidney disease?
Systematic Review
Do interventions incorporating therapeutic alliance improve medication adherence in Black patients with diabetes, hypertension, and kidney disease?
Interventions that incorporate therapeutic alliance and behavioral theories are effective in improving medication adherence among Black patients with diabetes and hypertension.
Supports integrating therapeutic alliance into adherence interventions for Black patients with diabetes or hypertension; extends evidence for behavioral theory-informed strategies.
Background: Black Americans have a disproportionately increased risk of diabetes, hypertension, and kidney disease, and higher associated morbidity, mortality, and hospitalization rates than their White peers. Structural racism amplifies these disparities, and negatively impacts self-care including medication adherence, critical to chronic disease management. Systematic evidence of successful interventions to improve medication adherence in Black patients with diabetes, hypertension, and kidney disease is lacking. Knowledge of the impact of therapeutic alliance, ie, the unique relationship between patients and providers, which optimizes outcomes especially for minority populations, is unclear. The role and application of behavioral theories in successful development of medication adherence interventions specific to this context also remains unclear. Objective: To evaluate the existing evidence on the salience of a therapeutic alliance in effective interventions to improve medication adherence in Black patients with diabetes, hypertension, or kidney disease. Data Sources: Medline (via PubMed), EMBASE (OvidSP), Cumulative Index of Nursing and Allied Health Literature (CINAHL) (EBSCOhost), and PsycINFO (ProQuest) databases. Review Methods: Only randomized clinical trials and pre/post intervention studies published in English between 2009 and 2022 with a proportion of Black patients greater than 25% were included. Narrative synthesis was done. Results: Eleven intervention studies met the study criteria and eight of those studies had all-Black samples. Medication adherence outcome measures were heterogenous. Five out of six studies which effectively improved medication adherence, incorporated therapeutic alliance. Seven studies informed by behavioral theories led to significant improvement in medication adherence. Discussion/Conclusion: Study findings suggest that therapeutic alliance-based interventions are effective in improving medication adherence in Black patients with diabetes and hypertension. Further research to test the efficacy of therapeutic alliance-based interventions to improve medication adherence in Black patients should ideally incorporate cultural adaptation, theoretical framework, face-to-face delivery mode, and convenient locations.
No takes yet. Share an insight, caveat, or question.
Desta et al. (2022) conducted a systematic review in Diabetes, hypertension, or kidney disease. Therapeutic alliance-based interventions vs. Various (Usual care, standard care, or active controls) was evaluated on Medication adherence. Therapeutic alliance-based interventions appear effective in improving medication adherence in Black patients with diabetes and hypertension, with 5 of the 6 successful studies incorporating this approach.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: